<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-37728</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0089167</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Lipoproteins</subject><subj-group><subject>Apolipoproteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical genetics</subject><subj-group><subject>Genetic testing</subject></subj-group></subj-group><subj-group><subject>Clinical research design</subject><subj-group><subject>Meta-analyses</subject></subj-group></subj-group><subj-group><subject>Endocrinology</subject><subj-group><subject>Diabetic endocrinology</subject><subj-group><subject>Diabetes mellitus type 2</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Genetic Polymorphism of Apolipoprotein A5 Gene and Susceptibility to Type 2 Diabetes Mellitus: A Meta-Analysis of 15,137 Subjects</article-title>
<alt-title alt-title-type="running-head">Association between APOA5 Polymorphism and T2DM</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yin</surname><given-names>Yan-Wei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>Qian-Qian</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Pei-Jian</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Qiao</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Ai-Min</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Hong-Li</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hou</surname><given-names>Zhi-Zhen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Emergency, Chinese PLA Air Force General Hospital, Haidian District, Beijing, China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Jinsong Sanatorium of Beijing Air Force, Beijing, China</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Cardiology, the First Affiliated Hospital, Chengdu Medical College, Chengdu, Sichuan, China</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Dermatology, Chinese PLA Air Force General Hospital, Haidian District, Beijing, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Katoh</surname><given-names>Masaru</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>National Cancer Center, Japan</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">shuaishuaijita@sohu.com</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: YWY. Performed the experiments: YWY QQS LQ AMH HLL QW ZZH. Analyzed the data: YWY QQS LQ. Contributed reagents/materials/analysis tools: QQS LQ. Wrote the paper: YWY QQS PJW.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>2</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>2</issue>
<elocation-id>e89167</elocation-id>
<history>
<date date-type="received"><day>12</day><month>9</month><year>2013</year></date>
<date date-type="accepted"><day>16</day><month>1</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Yin et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Several studies have investigated whether the polymorphism in the apolipoprotein A5 (APOA5) is associated with type 2 diabetes mellitus (T2DM) risk. However, those studies have produced inconsistent results. The purpose of this study was to investigate whether the APOA5 -1131T/C polymorphism (rs662799) confers significant susceptibility to T2DM using a meta-analysis.</p>
</sec><sec>
<title>Methods</title>
<p>PubMed, Embase, Web of Science, Cochrane database, CBMdisc, CNKI and Google Scholar were searched to get the genetic association studies. All statistical analyses were done with Stata 11.0.</p>
</sec><sec>
<title>Results</title>
<p>A total of 19 studies included 4,767 T2DM cases and 10,370 controls (four studies involving 555 T2DM cases and 2958 controls were performed among Europeans and 15 studies involving 4212 T2DM cases and 7412 controls were performed among Asians) were combined showing significant association between the APOA5 -1131T/C polymorphism and T2DM risk (for C allele vs. T allele: OR = 1.28, 95% CI = 1.17–1.40, <italic>p</italic>&lt;0.00001; for C/C vs. T/T: OR = 1.57, 95% CI = 1.35–1.83, <italic>p</italic>&lt;0.00001; for C/C vs. T/C+T/T: OR = 1.36, 95% CI = 1.18–1.57, <italic>p</italic>&lt;0.0001; for C/C+T/C vs. T/T: OR = 1.32, 95% CI = 1.16–1.51, <italic>p</italic>&lt;0.0001). In the subgroup analysis by ethnicity, significant association was also found among Asians (for C allele vs. T allele: OR = 1.31, 95% CI = 1.22–1.40, <italic>p</italic>&lt;0.00001; for C/C vs. T/T: OR = 1.61, 95% CI = 1.38–1.88, <italic>p</italic>&lt;0.00001; for C/C vs. T/C+T/T: OR = 1.39, 95% CI = 1.20–1.61, <italic>p</italic>&lt;0.0001; for C/C+T/C vs. T/T: OR = 1.42, 95% CI = 1.25–1.62, <italic>p</italic>&lt;0.00001). However, no significant association was found between the APOA5 -1131T/C polymorphism and T2DM risk among Europeans.</p>
</sec><sec>
<title>Conclusions</title>
<p>The present meta-analysis suggests that the APOA5 -1131T/C polymorphism is associated with an increased T2DM risk in Asian population.</p>
</sec></abstract>
<funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group><counts><page-count count="8"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Type 2 diabetes mellitus (T2DM) is a common, multifactorial disease that causes significant morbidity and mortality worldwide <xref ref-type="bibr" rid="pone.0089167-Gulliford1">[1]</xref>, <xref ref-type="bibr" rid="pone.0089167-International1">[2]</xref>. Although it results from synthetic action involving insulin resistance and impaired insulin secretion <xref ref-type="bibr" rid="pone.0089167-Lin1">[3]</xref>, a detailed etiology underlying T2DM is still unclear. Meanwhile, T2DM is a major factor that along with other risk factors such as obesity, endothelial dysfunction, and dyslipidemia contribute to atherosclerotic diseases. Therefore, it is vitally important to investigate the pathogenesis of T2DM.</p>
<p>Recently, numerous epidemiological studies have focused on the associations between the apolipoprotein A5 (APOA5) gene polymorphisms and T2DM risk, and indicate that the APOA5 gene polymorphisms exert important role in the development of T2DM <xref ref-type="bibr" rid="pone.0089167-Li1">[4]</xref>–<xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref>. APOA5 is a newly discovered member of the APOA4/APOC3/APOA1 apolipoprotein cluster <xref ref-type="bibr" rid="pone.0089167-Pennacchio1">[23]</xref>, <xref ref-type="bibr" rid="pone.0089167-vanderVliet1">[24]</xref>. The human APOA5 gene is located at chromosome 11q23 <xref ref-type="bibr" rid="pone.0089167-Ster1">[20]</xref>, displays a few polymorphisms in the promoter region (e.g., -1131T&gt;C, -3A&gt;G, S19W, IVS3+476G&gt;A, 1259T&gt;C, and G185C), which associated with high plasma triglyceride (TG) levels <xref ref-type="bibr" rid="pone.0089167-Pennacchio1">[23]</xref>, <xref ref-type="bibr" rid="pone.0089167-Aouizerat1">[25]</xref>–<xref ref-type="bibr" rid="pone.0089167-Pennacchio2">[28]</xref> and TG-related diseases such as metabolic syndrome <xref ref-type="bibr" rid="pone.0089167-Masz1">[29]</xref>, atherosclerotic diseases <xref ref-type="bibr" rid="pone.0089167-Li4">[30]</xref> and Alzheimer's disease <xref ref-type="bibr" rid="pone.0089167-Barbosa1">[31]</xref>. Previous meta-analyses have reported that the APOA5 -1131T/C polymorphism is associated with an increased risk for developing metabolic syndrome <xref ref-type="bibr" rid="pone.0089167-Xu1">[32]</xref>, <xref ref-type="bibr" rid="pone.0089167-Liu2">[33]</xref>. Here, we focused on the association between the APOA5 -1131T/C polymorphism and T2DM due to rare studies on other single-nucleotide polymorphisms. Until now, whether the APOA5 -1131T/C polymorphism is related to the risk of T2DM is still under debate. Most studies reported that the APOA5 -1131T/C polymorphism was associated with an increased risk of T2DM <xref ref-type="bibr" rid="pone.0089167-Yan1">[6]</xref>, <xref ref-type="bibr" rid="pone.0089167-Liu1">[7]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhai1">[11]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhou1">[12]</xref>, <xref ref-type="bibr" rid="pone.0089167-Qiao1">[14]</xref>–<xref ref-type="bibr" rid="pone.0089167-Zhang1">[16]</xref>, <xref ref-type="bibr" rid="pone.0089167-Bhaskar1">[19]</xref>. However, other studies demonstrated that there was no significant association between the APOA5 -1131T/C polymorphism and T2DM risk <xref ref-type="bibr" rid="pone.0089167-Li1">[4]</xref>, <xref ref-type="bibr" rid="pone.0089167-Chaaba1">[5]</xref>, <xref ref-type="bibr" rid="pone.0089167-Talmud1">[8]</xref>, <xref ref-type="bibr" rid="pone.0089167-Baum1">[9]</xref>, <xref ref-type="bibr" rid="pone.0089167-Li3">[17]</xref>, <xref ref-type="bibr" rid="pone.0089167-Xiao1">[18]</xref>, <xref ref-type="bibr" rid="pone.0089167-Ster1">[20]</xref>. Therefore, to better clarify the association between the APOA5 -1131T/C polymorphism and T2DM risk, we conducted a meta-analysis by collecting and sorting the previous published studies.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Literature search</title>
<p>We performed this meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria <xref ref-type="bibr" rid="pone.0089167-Moher1">[34]</xref>. Eligible literatures published before the end of October 2013 were identified by the search of PubMed, Embase, Web of Science, Cochrane database, CBMdisc, CNKI and Google Scholar using combinations of the following keywords: (apolipoprotein A5 OR APOA5 OR rs662799) AND (“polymorphism” OR “mutation” OR “variant” OR “variation” OR “genotype”) AND (type 2 diabetes mellitus OR type 2 diabetes OR diabetes mellitus OR diabetic patients OR T2DM). Furthermore, genome-wide association studies (GWAS) for T2DM were also identified by searching the above databases. Finally, the references of all selected studies were examined to identify additional work not indexed by electronic databases. There was no restriction on time period, sample size, population, or language.</p>
</sec><sec id="s2b">
<title>Inclusion criteria</title>
<p>The studies included in the meta-analysis must meet all the following inclusion criteria: (1) evaluation of the association between APOA5 -1131T/C polymorphism and T2DM risk; (2) the design had to be a case-control study or cohort study; (3) sufficient published data for calculating odds ratios (ORs) with their 95% confidence intervals (CIs); and (4) not republished data.</p>
</sec><sec id="s2c">
<title>Data extraction</title>
<p>For each study, the following information was extracted: name of the first author, year of publication, study population (country, ethnicity), source of controls (population-based studies and hospital-based studies), sample size (total numbers of cases and controls), and genotype frequency in cases and controls. Two authors (Yin YW and Sun QQ) independently assessed the articles for compliance with the inclusion criteria, resolved disagreements and reached a consistent decision.</p>
</sec><sec id="s2d">
<title>Quality score assessment</title>
<p>To determine the methodological quality of each study, we used the Newcastle-Ottawa scale (NOS), which uses a “star” rating system to judge the quality of observational studies <xref ref-type="bibr" rid="pone.0089167-Wells1">[35]</xref>. Three aspects of the study were assessed (selection, comparability, and exposure), and each satisfactory answer received one star. The NOS ranges between zero (worst) up to nine stars (best). Studies with a score of seven stars or greater are considered to be of high quality. Two authors (Liu HL and Wang Q) independently assessed the quality of included studies, and the result was reviewed by a third author (Wang Q). The discrepancy in quality assessment was discussed and resolved by the three authors.</p>
</sec><sec id="s2e">
<title>Statistical analysis</title>
<p>The strength of the association between the APOA5 -1131T/C polymorphism and T2DM risk was evaluated by the ORs with 95% CIs under the allelic model (C allele vs. T allele), additive model (C/C vs. T/T), recessive model (C/C vs. T/C+T/T), and dominant model (C/C+T/C vs. T/T). To adjust for multiple comparisons, we applied the Bonferroni method, which control for false positive error rate (<italic>p</italic>&lt;0.0125 was considered to be statistically significant). Hardy-Weinberg equilibrium (HWE) in the control group was assessed using the chi-square test (<italic>p</italic>&lt;0.05 was considered significant deviation from HWE).</p>
<p>Cochran's Q statistic and the I<sup>2</sup> statistic were performed to evaluate possible heterogeneity (<italic>p</italic>&lt;0.10 and I<sup>2</sup>&gt;50% indicated evidence of heterogeneity) <xref ref-type="bibr" rid="pone.0089167-Higgins1">[36]</xref>, <xref ref-type="bibr" rid="pone.0089167-Berkey1">[37]</xref>. A random-effects model or fixed-effects mode was used to calculate pooled OR in the presence or absence of heterogeneity, respectively. The sources of heterogeneity were also investigated by subgroup and sensitivity analyses. Subgroup analysis was performed based on ethnicity (Europeans and Asians). Sensitivity analyses were performed based on HWE (studies with HWE were included), NOS score (studies with score ≥7 were included), and source of controls (studies with population-based controls were included). Furthermore, Galbraith plot was used to further detect the potential sources of heterogeneity. Finally, publication bias was assessed by Begg's funnel plot <xref ref-type="bibr" rid="pone.0089167-Begg1">[38]</xref> and Egger's regression test <xref ref-type="bibr" rid="pone.0089167-Egger1">[39]</xref> (<italic>p</italic>&lt;0.05 was considered representative of statistically significant publication bias). Data analyses were performed using Stata software (Version 11; StataCorp LP, College Station, TX) and Review Manager software 5.1.4 (Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of the studies</title>
<p>The present study met the PRISMA statement requirements (<xref ref-type="supplementary-material" rid="pone.0089167.s001">Checklist S1</xref> and <xref ref-type="fig" rid="pone-0089167-g001">Fig. 1</xref>). The initial search identified 631 potentially eligible articles. Due to the high repetition rate of article in different databases, 460 articles were then excluded by reading the title. After reading the abstract and full text, 152 irrelevant articles were excluded. Finally, 19 eligible articles involving 4,767 T2DM cases and 10,370 controls were identified to assess the association of the APOA5 -1131T/C polymorphism with T2DM risk <xref ref-type="bibr" rid="pone.0089167-Li1">[4]</xref>–<xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref>. The baseline characteristics of 19 studies were shown in <xref ref-type="table" rid="pone-0089167-t001">Table 1</xref> and <xref ref-type="table" rid="pone-0089167-t002">2</xref>. Most studies were carried out among Asians and four studies were carried out among Europeans. Five studies did not follow the HWE <xref ref-type="bibr" rid="pone.0089167-Baum1">[9]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhou1">[12]</xref>, <xref ref-type="bibr" rid="pone.0089167-Li2">[15]</xref>, <xref ref-type="bibr" rid="pone.0089167-Xiao1">[18]</xref>, <xref ref-type="bibr" rid="pone.0089167-Ster1">[20]</xref> and one study had insufficient data for calculation of the HWE <xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref>. The NOS results showed that the average score was 7.6, which indicated that the methodological quality was generally good.</p>
<fig id="pone-0089167-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.g001</object-id><label>Figure 1</label><caption>
<title>Flow diagram of the study selection process.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0089167-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of studies included in this meta-analysis.</title>
</caption><alternatives><graphic id="pone-0089167-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Source of Controls</td>
<td align="left" rowspan="1" colspan="1">Sample size (case/control)</td>
<td colspan="5" align="left" rowspan="1">Genotypes distribution (case/control)</td>
<td align="left" rowspan="1" colspan="1">HWE</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">T/T</td>
<td align="left" rowspan="1" colspan="1">T/C</td>
<td align="left" rowspan="1" colspan="1">C/C</td>
<td align="left" rowspan="1" colspan="1">T</td>
<td align="left" rowspan="1" colspan="1">C</td>
<td align="left" rowspan="1" colspan="1">Y/N (P)</td>
<td align="left" rowspan="1" colspan="1">Score</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Li <xref ref-type="bibr" rid="pone.0089167-Li1">[4]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">214/472</td>
<td align="left" rowspan="1" colspan="1">96/225</td>
<td align="left" rowspan="1" colspan="1">85/196</td>
<td align="left" rowspan="1" colspan="1">33/51</td>
<td align="left" rowspan="1" colspan="1">277/646</td>
<td align="left" rowspan="1" colspan="1">151/298</td>
<td align="left" rowspan="1" colspan="1">Y(0.398)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Chaaba <xref ref-type="bibr" rid="pone.0089167-Chaaba1">[5]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Tunisia</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">152/156</td>
<td align="left" rowspan="1" colspan="1">108/115</td>
<td align="left" rowspan="1" colspan="1">38/36</td>
<td align="left" rowspan="1" colspan="1">6/5</td>
<td align="left" rowspan="1" colspan="1">254/266</td>
<td align="left" rowspan="1" colspan="1">50/46</td>
<td align="left" rowspan="1" colspan="1">Y(0.305)</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yan <xref ref-type="bibr" rid="pone.0089167-Yan1">[6]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">285/155</td>
<td align="left" rowspan="1" colspan="1">117/83</td>
<td align="left" rowspan="1" colspan="1">139/58</td>
<td align="left" rowspan="1" colspan="1">29/14</td>
<td align="left" rowspan="1" colspan="1">373/224</td>
<td align="left" rowspan="1" colspan="1">197/86</td>
<td align="left" rowspan="1" colspan="1">Y(0.407)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Liu <xref ref-type="bibr" rid="pone.0089167-Liu1">[7]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">465/502</td>
<td align="left" rowspan="1" colspan="1">171/246</td>
<td align="left" rowspan="1" colspan="1">225/212</td>
<td align="left" rowspan="1" colspan="1">69/44</td>
<td align="left" rowspan="1" colspan="1">567/704</td>
<td align="left" rowspan="1" colspan="1">363/300</td>
<td align="left" rowspan="1" colspan="1">Y(0.861)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Talmud <xref ref-type="bibr" rid="pone.0089167-Talmud1">[8]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">142/2348</td>
<td align="left" rowspan="1" colspan="1">131/2067</td>
<td align="left" rowspan="1" colspan="1">11/267</td>
<td align="left" rowspan="1" colspan="1">0/14</td>
<td align="left" rowspan="1" colspan="1">273/4401</td>
<td align="left" rowspan="1" colspan="1">11/295</td>
<td align="left" rowspan="1" colspan="1">Y(0.097)</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Baum <xref ref-type="bibr" rid="pone.0089167-Baum1">[9]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">749/198</td>
<td align="left" rowspan="1" colspan="1">373/109</td>
<td align="left" rowspan="1" colspan="1">283/65</td>
<td align="left" rowspan="1" colspan="1">93/24</td>
<td align="left" rowspan="1" colspan="1">1029/283</td>
<td align="left" rowspan="1" colspan="1">469/113</td>
<td align="left" rowspan="1" colspan="1">N(0.006)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cheng <xref ref-type="bibr" rid="pone.0089167-Cheng1">[10]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">275/113</td>
<td align="left" rowspan="1" colspan="1">108/57</td>
<td align="left" rowspan="1" colspan="1">139/48</td>
<td align="left" rowspan="1" colspan="1">28/8</td>
<td align="left" rowspan="1" colspan="1">355/162</td>
<td align="left" rowspan="1" colspan="1">195/64</td>
<td align="left" rowspan="1" colspan="1">Y(0.623)</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zhai <xref ref-type="bibr" rid="pone.0089167-Zhai1">[11]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">71/152</td>
<td align="left" rowspan="1" colspan="1">21/77</td>
<td align="left" rowspan="1" colspan="1">39/60</td>
<td align="left" rowspan="1" colspan="1">11/15</td>
<td align="left" rowspan="1" colspan="1">81/214</td>
<td align="left" rowspan="1" colspan="1">61/90</td>
<td align="left" rowspan="1" colspan="1">Y(0.514)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zhou <xref ref-type="bibr" rid="pone.0089167-Zhou1">[12]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">222/150</td>
<td align="left" rowspan="1" colspan="1">74/79</td>
<td align="left" rowspan="1" colspan="1">107/49</td>
<td align="left" rowspan="1" colspan="1">41/22</td>
<td align="left" rowspan="1" colspan="1">255/207</td>
<td align="left" rowspan="1" colspan="1">189/93</td>
<td align="left" rowspan="1" colspan="1">N(0.004)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Feng <xref ref-type="bibr" rid="pone.0089167-Feng1">[13]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">130/175</td>
<td align="left" rowspan="1" colspan="1">50/86</td>
<td align="left" rowspan="1" colspan="1">69/79</td>
<td align="left" rowspan="1" colspan="1">11/10</td>
<td align="left" rowspan="1" colspan="1">169/251</td>
<td align="left" rowspan="1" colspan="1">91/99</td>
<td align="left" rowspan="1" colspan="1">Y(0.136)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Qiao <xref ref-type="bibr" rid="pone.0089167-Qiao1">[14]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">154/206</td>
<td align="left" rowspan="1" colspan="1">85/117</td>
<td align="left" rowspan="1" colspan="1">52/79</td>
<td align="left" rowspan="1" colspan="1">17/10</td>
<td align="left" rowspan="1" colspan="1">222/313</td>
<td align="left" rowspan="1" colspan="1">86/99</td>
<td align="left" rowspan="1" colspan="1">Y(0.470)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Li <xref ref-type="bibr" rid="pone.0089167-Li2">[15]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">476/340</td>
<td align="left" rowspan="1" colspan="1">188/172</td>
<td align="left" rowspan="1" colspan="1">198/124</td>
<td align="left" rowspan="1" colspan="1">90/44</td>
<td align="left" rowspan="1" colspan="1">574/468</td>
<td align="left" rowspan="1" colspan="1">378/212</td>
<td align="left" rowspan="1" colspan="1">N(0.006)</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zhang <xref ref-type="bibr" rid="pone.0089167-Zhang1">[16]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">484/538</td>
<td align="left" rowspan="1" colspan="1">212/294</td>
<td align="left" rowspan="1" colspan="1">230/210</td>
<td align="left" rowspan="1" colspan="1">42/34</td>
<td align="left" rowspan="1" colspan="1">654/798</td>
<td align="left" rowspan="1" colspan="1">314/278</td>
<td align="left" rowspan="1" colspan="1">Y(0.667)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Li <xref ref-type="bibr" rid="pone.0089167-Li3">[17]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">45/40</td>
<td align="left" rowspan="1" colspan="1">30/27</td>
<td align="left" rowspan="1" colspan="1">9/10</td>
<td align="left" rowspan="1" colspan="1">6/3</td>
<td align="left" rowspan="1" colspan="1">69/64</td>
<td align="left" rowspan="1" colspan="1">21/16</td>
<td align="left" rowspan="1" colspan="1">Y(0.166)</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Xiao <xref ref-type="bibr" rid="pone.0089167-Xiao1">[18]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">54/108</td>
<td align="left" rowspan="1" colspan="1">26/54</td>
<td align="left" rowspan="1" colspan="1">16/35</td>
<td align="left" rowspan="1" colspan="1">12/19</td>
<td align="left" rowspan="1" colspan="1">68/143</td>
<td align="left" rowspan="1" colspan="1">40/73</td>
<td align="left" rowspan="1" colspan="1">N(0.004)</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bhaskar <xref ref-type="bibr" rid="pone.0089167-Bhaskar1">[19]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">310/120</td>
<td align="left" rowspan="1" colspan="1">151/70</td>
<td align="left" rowspan="1" colspan="1">130/41</td>
<td align="left" rowspan="1" colspan="1">29/9</td>
<td align="left" rowspan="1" colspan="1">432/181</td>
<td align="left" rowspan="1" colspan="1">188/59</td>
<td align="left" rowspan="1" colspan="1">Y(0.389)</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sóter <xref ref-type="bibr" rid="pone.0089167-Ster1">[20]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">146/173</td>
<td align="left" rowspan="1" colspan="1">111/134</td>
<td align="left" rowspan="1" colspan="1">34/33</td>
<td align="left" rowspan="1" colspan="1">1/6</td>
<td align="left" rowspan="1" colspan="1">256/301</td>
<td align="left" rowspan="1" colspan="1">36/45</td>
<td align="left" rowspan="1" colspan="1">N(0.039)</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yao <xref ref-type="bibr" rid="pone.0089167-Yao1">[21]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">278/4143</td>
<td align="left" rowspan="1" colspan="1">139/2065</td>
<td align="left" rowspan="1" colspan="1">116/1705</td>
<td align="left" rowspan="1" colspan="1">23/373</td>
<td align="left" rowspan="1" colspan="1">394/5835</td>
<td align="left" rowspan="1" colspan="1">162/2451</td>
<td align="left" rowspan="1" colspan="1">Y(0.434)</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">T/T</td>
<td align="left" rowspan="1" colspan="1">T/C+C/C</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Can Demirdöğen <xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">European</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">115/281</td>
<td align="left" rowspan="1" colspan="1">97/221</td>
<td align="left" rowspan="1" colspan="1">18/60</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">—</td>
<td align="left" rowspan="1" colspan="1">7</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>PB: population-based, HB: hospital-based.</p></fn><fn id="nt102"><label/><p>HWE: Hardy-Weinberg equilibrium, Y: yes, N: no.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0089167-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.t002</object-id><label>Table 2</label><caption>
<title>Meta-analyses of APOA5 -1131T/C polymorphism and risk of T2DM in each subgroup.</title>
</caption><alternatives><graphic id="pone-0089167-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Sample size (case/control)</td>
<td colspan="3" align="left" rowspan="1">Allelic model</td>
<td colspan="3" align="left" rowspan="1">Additive model</td>
<td colspan="3" align="left" rowspan="1">Recessive model</td>
<td colspan="3" align="left" rowspan="1">Dominant model</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Position</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1">P</td>
<td align="left" rowspan="1" colspan="1">P<sub>Q</sub>, I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1">P</td>
<td align="left" rowspan="1" colspan="1">P<sub>Q</sub>, I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1">P</td>
<td align="left" rowspan="1" colspan="1">P<sub>Q</sub>, I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95%CI)</td>
<td align="left" rowspan="1" colspan="1">P</td>
<td align="left" rowspan="1" colspan="1">P<sub>Q</sub>, I<sup>2</sup>(%)</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="14" align="left" rowspan="1">Overall analysis</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C</td>
<td align="left" rowspan="1" colspan="1">4767/10370</td>
<td align="left" rowspan="1" colspan="1">1.28[1.17,1.40]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.05(38%)</td>
<td align="left" rowspan="1" colspan="1">1.57[1.35,1.83]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.37(7%)</td>
<td align="left" rowspan="1" colspan="1">1.36[1.18,1.57]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.69(0%)</td>
<td align="left" rowspan="1" colspan="1">1.32[1.16,1.51]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.004(52%)</td>
</tr>
<tr>
<td colspan="14" align="left" rowspan="1">Subgroup analysis based on ethnicity</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C(E)</td>
<td align="left" rowspan="1" colspan="1">555/2958</td>
<td align="left" rowspan="1" colspan="1">0.91[0.69,1.20]</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
<td align="left" rowspan="1" colspan="1">0.25(28%)</td>
<td align="left" rowspan="1" colspan="1">0.68[0.27,1.70]</td>
<td align="left" rowspan="1" colspan="1">0.41</td>
<td align="left" rowspan="1" colspan="1">0.31(14%)</td>
<td align="left" rowspan="1" colspan="1">0.66[0.27,1.66]</td>
<td align="left" rowspan="1" colspan="1">0.38</td>
<td align="left" rowspan="1" colspan="1">0.31(15%)</td>
<td align="left" rowspan="1" colspan="1">0.88[0.67,1.15]</td>
<td align="left" rowspan="1" colspan="1">0.34</td>
<td align="left" rowspan="1" colspan="1">0.31(17%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C(A)</td>
<td align="left" rowspan="1" colspan="1">4212/7412</td>
<td align="left" rowspan="1" colspan="1">1.31[1.22,1.40]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.15(28%)</td>
<td align="left" rowspan="1" colspan="1">1.61[1.38,1.88]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.46(0%)</td>
<td align="left" rowspan="1" colspan="1">1.39[1.20,1.61]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.77(0%)</td>
<td align="left" rowspan="1" colspan="1">1.42[1.25,1.62]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.04(43%)</td>
</tr>
<tr>
<td colspan="14" align="left" rowspan="1">Sensitivity analysis</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C(BH)</td>
<td align="left" rowspan="1" colspan="1">3005/9120</td>
<td align="left" rowspan="1" colspan="1">1.27[1.14,1.42]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.05(42%)</td>
<td align="left" rowspan="1" colspan="1">1.61[1.34,1.93]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.49(0%)</td>
<td align="left" rowspan="1" colspan="1">1.41[1.18,1.68]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.76(0%)</td>
<td align="left" rowspan="1" colspan="1">1.33[1.14,1.56]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">0.0003</td>
<td align="left" rowspan="1" colspan="1">0.02(51%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C(BS)</td>
<td align="left" rowspan="1" colspan="1">4473/7866</td>
<td align="left" rowspan="1" colspan="1">1.30[1.21,1.39]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.13(30%)</td>
<td align="left" rowspan="1" colspan="1">1.58[1.36,1.84]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.29(14%)</td>
<td align="left" rowspan="1" colspan="1">1.37[1.18,1.58]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">0.58(0%)</td>
<td align="left" rowspan="1" colspan="1">1.37[1.20,1.56]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.01(49%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-1131T/C(BC)</td>
<td align="left" rowspan="1" colspan="1">4222/5790</td>
<td align="left" rowspan="1" colspan="1">1.34[1.24,1.44]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.26(16%)</td>
<td align="left" rowspan="1" colspan="1">1.69[1.44,1.99]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.70(0%)</td>
<td align="left" rowspan="1" colspan="1">1.44[1.23,1.68]</td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.83(0%)</td>
<td align="left" rowspan="1" colspan="1">1.42[1.25,1.61]<xref ref-type="table-fn" rid="nt107">a</xref></td>
<td align="left" rowspan="1" colspan="1">&lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">0.06(38%)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>A: Asians, E: Europeans.</p></fn><fn id="nt104"><label/><p>BH: based on HWE (studies with HWE were included).</p></fn><fn id="nt105"><label/><p>BS: based on NOS score (studies with score ≥7 were included).</p></fn><fn id="nt106"><label/><p>BC: based on source of controls (studies with population-based controls were included).</p></fn><fn id="nt107"><label>a</label><p>Significant heterogeneity: the random-effects model was chosen to summarize the result.</p></fn><fn id="nt108"><label/><p>P<sub>Q</sub>: P values for heterogeneity from Q-test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Quantitative synthesis</title>
<p>Given that significant heterogeneity existed in the allelic model and dominant model, we chose the random-effects model to synthesize the data of these two genetic models. As for the additive model and recessive model, no heterogeneity was found in these two genetic models. Therefore, we used fixed-effects model to analyze the data of additive and recessive models. The overall results showed evidence of significant association between the APOA5 -1131T/C polymorphism and T2DM risk, suggesting that the APOA5 -1131T/C polymorphism was a risk factor for T2DM (for C allele vs. T allele: OR = 1.28, 95% CI = 1.17–1.40, <italic>p</italic>&lt;0.00001; for C/C vs. T/T: OR = 1.57, 95% CI = 1.35–1.83, <italic>p</italic>&lt;0.00001; for C/C vs. T/C+T/T: OR = 1.36, 95% CI = 1.18–1.57, <italic>p</italic>&lt;0.0001; for C/C+T/C vs. T/T: OR = 1.32, 95% CI = 1.16–1.51, <italic>p</italic>&lt;0.0001). The main results of meta-analysis were shown in <xref ref-type="table" rid="pone-0089167-t002">Table 2</xref> and <xref ref-type="fig" rid="pone-0089167-g002">Fig. 2</xref>.</p>
<fig id="pone-0089167-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.g002</object-id><label>Figure 2</label><caption>
<title>Forest plots for APOA5 -1131T/C polymorphism and T2DM risk.</title>
<p>(A). Allelic model: C allele vs. T allele; (B). Additive model: C/C vs. T/T (C). Recessive model: C/C vs. T/C+T/T; (D). Dominant model: C/C+T/C vs. T/T.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.g002" position="float" xlink:type="simple"/></fig>
<p>In the subgroup analysis based on ethnicity, significant association was also found between the APOA5 -1131T/C polymorphism and T2DM risk in Asians (for C allele vs. T allele: OR = 1.31, 95% CI = 1.22–1.40, <italic>p</italic>&lt;0.00001; for C/C vs. T/T: OR = 1.61, 95% CI = 1.38–1.88, <italic>p</italic>&lt;0.00001; for C/C vs. T/C+T/T: OR = 1.39, 95% CI = 1.20–1.61, <italic>p</italic>&lt;0.0001; for C/C+T/C vs. T/T: OR = 1.42, 95% CI = 1.25–1.62, <italic>p</italic>&lt;0.00001), but not in Europeans (for C allele vs. T allele: OR = 0.91, 95% CI = 0.69–1.20, <italic>p</italic> = 0.49; for C/C vs. T/T: OR = 0.68, 95% CI = 0.27–1.70, <italic>p</italic> = 0.41; for C/C vs. T/C+T/T: OR = 0.66, 95% CI = 0.27–1.66, <italic>p</italic> = 0.38; for C/C+T/C vs. T/T: OR = 0.88, 95% CI = 0.67–1.15, <italic>p</italic> = 0.34). The main results of subgroup analysis were shown in <xref ref-type="table" rid="pone-0089167-t002">Table 2</xref>.</p>
</sec><sec id="s3c">
<title>Sensitivity analysis</title>
<p>Sensitivity analyses were respectively performed based on HWE (studies with HWE were included), NOS score (studies with score ≥7 were included), and source of controls (studies with population-based controls were included). Overall, the pooled ORs and 95% CIs were not materially altered when any part of the study was omitted, indicating that our results were statistically robust. The results of sensitivity analyses were shown in <xref ref-type="table" rid="pone-0089167-t002">Table 2</xref>.</p>
</sec><sec id="s3d">
<title>Heterogeneity analysis</title>
<p>Significant heterogeneity existed in the allelic model (P<sub>Q</sub> = 0.05, I<sup>2</sup> = 38%) and dominant model (P<sub>Q</sub> = 0.004, I<sup>2</sup> = 52%). In contrast, the additive model (P<sub>Q</sub> = 0.37, I<sup>2</sup> = 7%) and recessive model (P<sub>Q</sub> = 0.69, I<sup>2</sup> = 0%) did not present significant heterogeneity. To clarify the sources of heterogeneity, we first conducted the subgroup and sensitivity analyses. We only effectively removed the heterogeneity in the European group. We next created a Galbraith plot to graphically assess the sources of heterogeneity. A total of four studies <xref ref-type="bibr" rid="pone.0089167-Talmud1">[8]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhou1">[12]</xref>, <xref ref-type="bibr" rid="pone.0089167-Yao1">[21]</xref>, <xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref> were identified as the main contributors to heterogeneity (<xref ref-type="fig" rid="pone-0089167-g003">Fig. 3</xref>). After excluding the outlier studies, the heterogeneity was effectively removed (data not shown).</p>
<fig id="pone-0089167-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.g003</object-id><label>Figure 3</label><caption>
<title>Galbraith plots for APOA5 -1131T/C polymorphism and T2DM risk.</title>
<p>(A). Allelic model: C allele vs. T allele; (B). Dominant model: C/C+T/C vs. T/T.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Publication bias evaluation</title>
<p>Begg's funnel plot and Egger's regression test were performed to assess potential publication bias. The funnel plot did not show obvious asymmetry in any genetic model (<xref ref-type="fig" rid="pone-0089167-g004">Fig. 4</xref>). In addition, the results of Egger's regression test did not provide any statistical evidence for publication bias (<italic>p</italic> = 0.475 for allelic model, <italic>p</italic> = 0.647 for additive model, <italic>p</italic> = 0.581 for recessive model, and <italic>p</italic> = 0.452 for dominant model). Therefore, there was no risk of publication bias in the present meta-analysis.</p>
<fig id="pone-0089167-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0089167.g004</object-id><label>Figure 4</label><caption>
<title>Funnel plots for APOA5 -1131T/C polymorphism and T2DM risk.</title>
<p>(A). Allelic model: C allele vs. T allele; (B). Additive model: C/C vs. T/T (C). Recessive model: C/C vs. T/C+T/T; (D). Dominant model: C/C+T/C vs. T/T.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0089167.g004" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>The APOA5 gene was identified by Pennacchio et al. in 2001 <xref ref-type="bibr" rid="pone.0089167-Pennacchio1">[23]</xref>. Since then, the association of APOA5 -1131T/C polymorphism with the susceptibility to T2DM has been widely studied; however, the results are conflicting <xref ref-type="bibr" rid="pone.0089167-Li1">[4]</xref>–<xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref>. Moreover, the credibility of results from a single case-control study is questionable due to too small sample size of the study populations. Recently, meta-analysis has been widely used in genetic association studies beacuse it has the potential to detect small effects between gene polymorphism and human disease <xref ref-type="bibr" rid="pone.0089167-Yin1">[40]</xref>, <xref ref-type="bibr" rid="pone.0089167-Yin2">[41]</xref>. A previous meta-analysis has reported that the APOA5 -1131T/C polymorphism is associated with an increased T2DM risk <xref ref-type="bibr" rid="pone.0089167-Tang1">[42]</xref>. Consistently, the present meta-analysis obtained the similar conclusion. However, only five studies <xref ref-type="bibr" rid="pone.0089167-Yan1">[6]</xref>, <xref ref-type="bibr" rid="pone.0089167-Talmud1">[8]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhai1">[11]</xref>, <xref ref-type="bibr" rid="pone.0089167-Qiao1">[14]</xref>, <xref ref-type="bibr" rid="pone.0089167-Li2">[15]</xref> were included in the previous meta-analysis and thus, unable to provide enough persuasiveness. Therefore, a large-scale meta-analysis evaluating the precise association between the APOA5 -1131T/C polymorphism and T2DM risk is required.</p>
<p>To the best of our knowledge, this is the first comprehensive meta-analysis to date investigating the association between the APOA5 -1131T/C polymorphism and T2DM risk. Nineteen studies involving 4,767 T2DM cases and 10,370 controls were included in the present meta-analysis. The overall results showed that there was significant association between the APOA5 -1131T/C polymorphism and the T2DM risk, suggesting the C allele was a independent risk factor for the development of T2DM. The findings showed that the risk of developing T2DM in C allele carriers was 1.32-fold higher than those without. Furthermore, the individuals with C/C genotype had a significantly higher risk for developing T2DM (for OR = 1.57 in additive model and OR = 1.36 in recessive model) compared to those with T/C genotype and T/T genotype.</p>
<p>Considering that potential ethnic difference might be associated with the distribution of genotypes, we also performed subgroup analysis by ethnicity of study population. We only obtained the positive result in the Asians, which further consolidated the overall results. For Europeans, we did not find significant association between the APOA5 -1131T/C polymorphism and T2DM risk. Actually, the minor allele frequency (MAF) of APOA5 -1131T/C is very low among utah residents with Northern and Western European ancestry (CEU) (MAF = 0.015 in HapMap CEU) <xref ref-type="bibr" rid="pone.0089167-International2">[43]</xref>. However, the APOA5 -1131T/C polymorphism is common among Han Chinese in Beijing, China (CHB) and Japanese in Tokyo, Japan (JPT) (MAF = 0.267 and 0.291, respectively) <xref ref-type="bibr" rid="pone.0089167-International2">[43]</xref>. Compared with the overall results, the inconsistent results of European group may partly result from genetic diversity among ethnicities. In addition, the number of the studies and the number of European subjects included in this meta-analysis are relatively small (four studies involving 555 T2DM cases and 2958 controls), which could increase the probability of false negatives. Therefore, the results of European group should be interpreted with caution. In addition to the subgroup analysis, sensitivity analyses were also conducted to ascertain whether modification of the inclusion criteria of the meta-analysis affected the final results. The corresponding pooled ORs were not materially altered in all comparisons. The results of sensitivity analyses indicated that our overall results were statistically robust. Furthermore, they also suggested that the studies with hospital-based controls, low NOS score or without HWE should be not considered as a factor influencing the overall results.</p>
<p>In the present meta-analysis, we found significant association between the APOA5 -1131T/C polymorphism and T2DM risk, particularly in Asian population. However, so far no definite evidence exists to support that the APOA5 -1131T/C polymorphism is directly related to T2DM susceptibility. It is well known that high plasma TG level is an important risk factor in developing T2DM <xref ref-type="bibr" rid="pone.0089167-Wang1">[44]</xref>. In 2012, Wang et al. found that the baseline TG level was independently associated with T2DM onset risk, and the change of TG level in a 15-year interval predicts the onset risk of T2DM beyond the baseline TG level <xref ref-type="bibr" rid="pone.0089167-Wang1">[44]</xref>. Given the large genetic effect of the APOA5 -1131T/C polymorphism on plasma TG level, the observed association between this variant and T2DM might be due to the correlation between the plasma TG level and T2DM risk. Therefore, projections from the literature of who is at risk for APOA5 gene attributable T2DM and who would benefit from APOA5 gene-targeted therapies should be approached with caution.</p>
<p>Between-study heterogeneity should not be ignored and should be carefully factored in the interpretation of the finally results <xref ref-type="bibr" rid="pone.0089167-Ioannidis1">[45]</xref>, which was also observed in our meta-analysis regarding the allelic model and dominant model. After subgroup and sensitivity analyses, we effectively removed the heterogeneity in the European group. Therefore, the heterogeneity might partly result from the ethnicity difference or the Asian group. However, it should be noted that only four studies involving European subjects were included in the present meta-analysis, which could increase the probability of false positives. Therefore, this result of heterogeneity analysis should be interpreted with caution. In addition to the European group, the heterogeneity in some comparison groups remained significant. To further explore the sources of heterogeneity, we created a Galbraith plot to identify potential outlier studies. A total of four studies <xref ref-type="bibr" rid="pone.0089167-Talmud1">[8]</xref>, <xref ref-type="bibr" rid="pone.0089167-Zhou1">[12]</xref>, <xref ref-type="bibr" rid="pone.0089167-Yao1">[21]</xref>, <xref ref-type="bibr" rid="pone.0089167-CanDemirden1">[22]</xref> were identified as the main contributors to heterogeneity (<xref ref-type="fig" rid="pone-0089167-g003">Fig. 3</xref>). After excluding the outlier studies, the heterogeneity was effectively removed in the allelic model and dominant model. Furthermore, the corresponding pooled ORs were not materially altered in all comparisons, suggesting the overall results of this meta-analysis were statistically robust.</p>
<p>For better interpreting the results, some limitations of this meta-analysis should be acknowledged. Firstly, there was significant between-study heterogeneity in the allelic model and dominant model. Heterogeneity is a problem that may affect the precision of overall results. Secondly, in 19 studies included in this meta-analysis, only four of them are European samples, which may develop a partial result. Thirdly, the controls were not uniformly defined. Both healthy individuals and patients without T2DM in hospital were included in the control group. The hospital-based controls may not be representative of the randomized population. Therefore, some inevitable selection bias might be brought into the meta-analyses, which might affect the interpretation of the final results. Moreover, meta-analysis is a type of retrospective study, and recall and selection bias might inevitably exist.</p>
<p>In conclusion, the present meta-analysis suggests that the APOA5 -1131T/C polymorphism is associated with an increased T2DM risk in Asian population. However, the result should be interpreted with caution because of its limitations. Larger and well-designed studies based on different ethnic samples are needed to confirm our results in the future.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0089167.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0089167.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA 2009 checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0089167-Gulliford1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gulliford</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Charlton</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title>Is relative mortality of type 2 diabetes mellitus decreasing?</article-title>. <source>Am J Epidemiol</source> <volume>169</volume>: <fpage>455</fpage>–<lpage>461</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-International1"><label>2</label>
<mixed-citation publication-type="other" xlink:type="simple">International Diabetes Federation (2012) Available at: <ext-link ext-link-type="uri" xlink:href="http://www.diabetesatlas.org/content/diabetes" xlink:type="simple">http://www.diabetesatlas.org/content/diabetes</ext-link>. Accessed: Feb 10, 2012.</mixed-citation>
</ref>
<ref id="pone.0089167-Lin1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Hsia</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>CZ</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>WY</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus</article-title>. <source>Metabolism</source> <volume>59</volume>: <fpage>780</fpage>–<lpage>786</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Li1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>XF</given-names></name> (<year>2002</year>) <article-title>Study on the association of apolipoprotein A5 gene single nucleotide polymorphisms with type II diabetes</article-title>. <source>Fujian Medical University (Master thesis)</source> <fpage>1</fpage>–<lpage>51</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Chaaba1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chaaba</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Attia</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hammami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Smaoui</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mahjoub</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes</article-title>. <source>Lipids Health Dis</source> <volume>4</volume>: <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Yan1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>XQ</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Apolipoprotein A5 gene polymorphism -1131T–&gt;C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese</article-title>. <source>Clin Chem Lab Med</source> <volume>43</volume>: <fpage>607</fpage>–<lpage>612</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Liu1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>HK</given-names></name> (<year>2005</year>) <article-title>Study on the association of single nucleotide polymorphisms in apolipoprotein APOA I/C3/A4/A5 gene cluster with coronary heart disease and type II diabetes</article-title>. <source>Sichuan University (Doctor thesis)</source> <fpage>1</fpage>–<lpage>108</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Talmud1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Talmud</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>GJ</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II</article-title>. <source>Diabetologia</source> <volume>49</volume>: <fpage>2337</fpage>–<lpage>2340</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Baum1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baum</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>So</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A case-control study of apoA5 -1131T–&gt;C polymorphism that examines the role of triglyceride levels in diabetic nephropathy</article-title>. <source>J Diabetes Complications</source> <volume>21</volume>: <fpage>158</fpage>–<lpage>163</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Cheng1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname><given-names>XQ</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Relationship between Apolipoprotein AV gene-1131T&gt;C polymorphism and Type 2 Diabetes Mellitus with Coronary Heart Disease in Han Nationality</article-title>. <source>Molecular Cardiology of China</source> <volume>7</volume>: <fpage>189</fpage>–<lpage>194</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Zhai1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhai</surname><given-names>GH</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>Association of apolipoprotein A5 gene -1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus</article-title>. <source>HEREDITAS (Beijing)</source> <fpage>541</fpage>–<lpage>546</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Zhou1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>XY</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>MA</given-names></name> (<year>2008</year>) <article-title>Study on the relationship between apolipoprotein A5 gene polymorphism and type 2 diabetic mellitus retinopathy</article-title>. <source>Journal of Chinese Practical Diagnosis and Therapy</source> <volume>22</volume>: <fpage>815</fpage>–<lpage>817</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Feng1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feng</surname><given-names>CS</given-names></name> (<year>2009</year>) <article-title>The Relationships of CYP11B2, ApoA5 Gene Polymorphisms and Type 2 Diabetes with Nephropathy</article-title>. <source>Qingdao University (Master thesis)</source> <fpage>1</fpage>–<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Qiao1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qiang</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Association of Apolipoprotein A5 Gene-1131T/C Polymorphism with Serum Lipids and Carotid Intima-media Thickness in Patients with Type 2 Diabetes Mellitus</article-title>. <source>Journal of Sichuan University(Medical Science Edition)</source> <volume>39</volume>: <fpage>965</fpage>–<lpage>968</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Li2"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes</article-title>. <source>J Huazhong Univ Sci Technolog Med Sci</source> <volume>28</volume>: <fpage>653</fpage>–<lpage>656</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Zhang1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>Relationship between Apolipoprotein AV Gene-1131T/C Polymorphism and Type 2 Diabetes Mellitus in Han Nationality</article-title>. <source>Zhongshan University (Master thesis)</source> <fpage>1</fpage>–<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Li3"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>HX</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>ZP</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>YG</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name> (<year>2009</year>) <article-title>Study on the Relationship of Apolipoprotein A5 Gene-1131T/C Polymorphism with lipid protein(a) and homocysteinemia levels in patients with diabetic nephropathy</article-title>. <source>China Practical Medicine</source> <volume>4</volume>: <fpage>40</fpage>–<lpage>42</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Xiao1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>HQ</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Study on the association of APOA5 -1131T/C gene polymorphism with 2 diabetes in uygurs</article-title>. <source>Modern Preventive Medicine</source> <volume>37</volume>: <fpage>722</fpage>–<lpage>732</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Bhaskar1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhaskar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ganesan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chandak</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Mani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Idris</surname><given-names>MM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes</article-title>. <source>Genet Test Mol Biomarkers</source> <volume>15</volume>: <fpage>507</fpage>–<lpage>512</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Ster1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sóter</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Fernandes</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>Md</given-names></name>, <name name-style="western"><surname>Pinheiro</surname><given-names>PS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>-1131T&gt;C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>7541</fpage>–<lpage>7548</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Yao1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yao</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>NX</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Genetically elevated levels of circulating triglycerides and brachial-ankle pulse wave velocity in a Chinese population</article-title>. <source>J Hum Hypertens</source> <volume>27</volume>: <fpage>265</fpage>–<lpage>270</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-CanDemirden1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Can Demirdöğen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Şahin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Türkanoğlu Özçelik</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bek</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>10459</fpage>–<lpage>10468</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Pennacchio1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pennacchio</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Olivier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hubacek</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>DR</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing</article-title>. <source>Science</source> <volume>294</volume>: <fpage>169</fpage>–<lpage>173</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-vanderVliet1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van der Vliet</surname><given-names>HN</given-names></name>, <name name-style="western"><surname>Sammels</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Leegwater</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Levels</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Reitsma</surname><given-names>PH</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration</article-title>. <source>J Biol Chem</source> <volume>276</volume>: <fpage>44512</fpage>–<lpage>44520</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Aouizerat1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aouizerat</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Kulkarni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Heilbron</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Drown</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Raskin</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids</article-title>. <source>J Lipid Res</source> <volume>44</volume>: <fpage>1167</fpage>–<lpage>1173</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Austin1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Austin</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Talmud</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Farin</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Nickerson</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans</article-title>. <source>Biochim Biophys Acta</source> <volume>1688</volume>: <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Martin1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nicaud</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Humphries</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Talmud</surname><given-names>PJ</given-names></name> (<year>2003</year>) <collab xlink:type="simple">EARS group</collab> (<year>2003</year>) <article-title>Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges</article-title>. <source>Biochim Biophys Acta</source> <volume>1637</volume>: <fpage>217</fpage>–<lpage>225</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Pennacchio2"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pennacchio</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Olivier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hubacek</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Krauss</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>EM</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels</article-title>. <source>Hum Mol Genet</source> <volume>11</volume>: <fpage>3031</fpage>–<lpage>3038</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Masz1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maász</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kisfali</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Horvatovich</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mohás</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Markó</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome</article-title>. <source>Pathol Oncol Res</source> <volume>13</volume>: <fpage>243</fpage>–<lpage>247</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Li4"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name> (<year>2007</year>) <article-title>Association of APOA5 gene polymorphism with levels of lipids and atherosclerotic cerebral infarction in Chinese</article-title>. <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chinese)</source> <volume>24</volume>: <fpage>576</fpage>–<lpage>578</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Barbosa1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barbosa</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>de Labio</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>de Oliveira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rigolin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Minett</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bertolucci</surname><given-names>PH</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Apolipoprotein A-V gene polymorphism -1131T&gt;C and Alzheimer's disease</article-title>. <source>J Alzheimers Dis</source> <volume>10</volume>: <fpage>365</fpage>–<lpage>369</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Xu1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Effects of APOA5 -1131T&gt;C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e56216</fpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Liu2"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>QF</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CY</given-names></name> (<year>2012</year>) <article-title>Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: a meta-analysis</article-title>. <source>Genet Test Mol Biomarkers</source> <volume>16</volume>: <fpage>1241</fpage>–<lpage>1245</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Moher1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2009</year>) <collab xlink:type="simple">PRISMA Group</collab> (<year>2009</year>) <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Ann Intern Med</source> <volume>151</volume>: <fpage>264</fpage>–<lpage>269</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Wells1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wells</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Shea</surname><given-names>B</given-names></name>, <name name-style="western"><surname>O'Connell</surname><given-names>D</given-names></name> (<year>2011</year>) <article-title>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses</article-title>. <source>Ottawa Health Research Institute</source> <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link> (accessed Oct 20, 2011).</mixed-citation>
</ref>
<ref id="pone.0089167-Higgins1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Berkey1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berkey</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hoaglin</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Mosteller</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Colditz</surname><given-names>GA</given-names></name> (<year>1995</year>) <article-title>A random-effects regression model for meta-analysis</article-title>. <source>Stat Med</source> <volume>14</volume>: <fpage>395</fpage>–<lpage>411</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Begg1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Egger1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Yin1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>QQ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>HL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Association between Apolipoprotein E Gene Polymorphism and the Risk of Coronary Artery Disease in Chinese Population: Evidence from a Meta-Analysis of 40 Studies</article-title>. <source>PLoS One</source> <volume>2013;8</volume> (<issue>6</issue>) <fpage>e66924</fpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Yin2"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>QQ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>HL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Association between interleukin 10 gene -1082 A/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis of 4250 subjects</article-title>. <source>Cytokine</source> <volume>62</volume>: <fpage>226</fpage>–<lpage>231</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Tang1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e70301</fpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-International2"><label>43</label>
<mixed-citation publication-type="other" xlink:type="simple">International HapMap Project (2013) Available at: <ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov" xlink:type="simple">http://hapmap.ncbi.nlm.nih.gov</ext-link>. Accessed: October 29, 2013.</mixed-citation>
</ref>
<ref id="pone.0089167-Wang1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The association between the changes in triglyceride levels and the risk of incident type 2diabetes mellitus: a 15 years followed-up results from the Chinese Multi-provincial Cohort Study</article-title>. <source>Zhonghua Nei Ke Za Zhi</source> <volume>51</volume>: <fpage>516</fpage>–<lpage>519</lpage>.</mixed-citation>
</ref>
<ref id="pone.0089167-Ioannidis1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Patsopoulos</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Evangelou</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>Heterogeneity in meta-analyses of genome-wide association investigations</article-title>. <source>PLoS One</source> <volume>2</volume>: <fpage>e841</fpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>